The aim of this work is the evaluation of four different heat exchangers used for myocardium during cardioplegic system in cardiac surgeries. Four types of shell and tube heat exchangers made of different exchange elements were constructed, as follows: stainless steel tubes, aluminium tubes, polypropylene hollow fiber, and bellows type. The evaluation was performed by in vitro tests of parameters such as heat transfer, pressure drop, and hemolysis tendency. The result has shown that all four systems tested were able to achieve the heat performance, and to offer low resistance to flow, and safety, as well as have low tendency to hemolysis. However, we can emphasize that the bellows type heat exchanger has a significant difference with regard to the other three types.
RBCCV 44205-782Desenvolvimento tecnológico dos oxigenadores de membrana Technological evolution of membrane oxygenatorsDescriptors: Oxygenators, membrane. Extracorporeal circulation.Descritores: Oxigenadores de membrana. Circulação extracorpórea. INTRODUCTIONThe first attempts of oxygenating blood outside the body were made by physiologists in the XIX century in their studies on perfusion of organs isolated from animals.The first modern studies dedicated to artificial oxygenation of blood, with the objective of maintaining the life of an organism, dated from 1937 and were performed by John Gibbon [1]. In the years that followed, Gibbon dedicated his research to the improvement of this revolutionary technique [2][3][4]. Several researchers, encouraged by the possibility of building apparatuses capable of replacing cardiopulmonary functions, started to build oxygenators [5][6][7].Oxygenators must be capable of oxygenating approximately five liters of blood per minute and to remove the carbon dioxide (CO 2 ) in order to artificially support the life of an adult. Moreover, heat exchange must be optimized in the least possible surface area, whilst the trauma caused to blood elements must be minimal. The priming necessary to operate the apparatus must also be small, in order to allow its use with acellular solutions, avoiding excessive hemodilution and unnecessary transfusions of blood or blood derivatives [8].Several forms of supplying oxygen (O 2 ) to the blood have been attempted, with more or less success, enabling the development of many models of oxygenators of which only a few have been clinically employed. DRUMMOND, M ET AL -Technological evolution of membrane oxygenatorsBraz J Cardiovasc Surg 2005; 20(4): 432-437 Later, other membrane oxygenators with similar configurations to the original project of Clowes & Neville [16] were used [5,17,18]. Kolobow et al. [19], based on the Kolff model, projected an oxygenator composed of long strips of silicon sustained by an envelope with spacers to stop the membranes from sticking together. In this model, the blood flowed inside the strips and O 2 circulated parallel to the central axis that sustained the reel of membranes. As this model functioned adequately for long periods, it was utilized in prolonged ventilatory support procedures. The Kolobow oxygenator was continuously improved and is currently produced and sold by the American Company, Avecor. It is the only oxygenator on the market recommended for prolonged use.The first-generation membrane oxygenators had great resistance to the passage of blood through the membranes which was impossible to overcome by siphoning alone. Some apparatuses were set up on the side of the positive pressure of a peristaltic pump, whilst others required an additional pump to circulate the blood in the membrane chamber. Because of the difficulties with gas exchanges and the complexity of their construction and use, the first-generation membrane oxygenators were not very well accepted. The development of technology to produce expand...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.